Using a high-throughput proteomic approach, label-free liquid chromatography–tandem mass spectrometry of cerebrospinal fluid (CSF) samples from DLB patients identified PCSK1N, NPTXR, VGF, PDYN, SCG2, and NPTX2. This evidence concerns the gene PCSK1N and Lewy body dementia.